Hemant Surgical

{
  "main_header": {
    "sid": 1003854,
    "name": "Hemant Surgical",
    "stock_name": "Hemant Surgical",
    "full_name": "Hemant Surgical Industries Ltd",
    "name_url": "stocks-analysis/hemant-surgical",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "285.00",
    "chg": "0.00",
    "chgp": "0.00%",
    "dir": 0,
    "prev_price": "285.00",
    "mcapval": "372.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 543916,
    "symbol": "",
    "ind_name": "Healthcare Services",
    "ind_code": 94,
    "indexname": "",
    "isin": "INE0GYI01028",
    "curr_date": "Feb 11",
    "curr_time": "",
    "bse_nse_vol": 400,
    "exc_status": "Active",
    "traded_date": "Feb 11, 2026",
    "traded_date_str": "2026 02 11",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/hemant-surgical-1003854-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Why is Hemant Surgical falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-hemant-surgical-fallingrising-3722310",
        "imagepath": "",
        "date": "2025-11-22 01:30:28",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Short-Term Price Movement and Market Context</strong></p>\n<p>Hemant Surgical's share price decline on 21-Nov reflects a short-term correction after a period of strong gains. The stock underperformed its sector by 2.99% on the day, touching an intraday low of ₹275.05. This contrasts with the broader Sensex, which has shown modest positive returns over the past week and month. Specifically, while the Sensex gained 0.79% over the last week, Hemant Surgical's shares fell by 5.16% during the same period, indicating a divergence from general market trends.</p>\n<p>The stock's current price sits above its 100-day and 200-day moving averages, signalling a longer-term bullish trend. However, it remains below its 5-day, 20-day, and 50-day moving averages, suggesting recent downward momentum. This techn..."
      },
      {
        "title": "Is Hemant Surgical overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-hemant-surgical-overvalued-or-undervalued-3713644",
        "imagepath": "",
        "date": "2025-11-19 08:10:08",
        "description": "As of 18 November 2025, the valuation grade for Hemant Surgical has moved from very expensive to expensive. The company is currently considered overvalued. Key ratios include a PE ratio of 45.47, an EV to EBITDA of 38.49, and a Price to Book Value of 3.28. In comparison to peers, Max Healthcare has a significantly higher PE ratio of 77.03, while Apollo Hospitals is at 63.51, indicating that Hemant Surgical's valuation remains elevated relative to its competitors.\n\nDespite a strong year-to-date return of 124.64% compared to the Sensex's 8.36%, the high valuation ratios suggest that the stock is not justified at its current price of 283.50. The company's ROCE of 8.31% and ROE of 7.22% further indicate that while it has performed well, the market may be pricing in growth that is not fully supported by its financial metrics...."
      }
    ],
    "total": 157,
    "sid": "1003854",
    "stock_news_url": "https://www.marketsmojo.com/news/hemant-surgical-industries-1003854"
  },
  "announcements": [
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "12-Jan-2026",
      "details": "Certificate under Reg. 74(5) of SEBI (DP) Regulation 2018.",
      "source": "BSE"
    },
    {
      "caption": "Statement Of Deviation Or Variation Pursuant To Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
      "datetime": "12-Nov-2025",
      "details": "Statement of Deviation or Variation for half year ended on September 30 2025",
      "source": "BSE"
    },
    {
      "caption": "Un-Audited Financial Results Of The Company For The Half Year Ended On September 30 2025.",
      "datetime": "12-Nov-2025",
      "details": "Unaudited financial results of the Company for the half year ended on September 30 2025.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Why is Hemant Surgical falling/rising?

2025-11-22 01:30:28

Short-Term Price Movement and Market Context

Hemant Surgical's share price decline on 21-Nov reflects a short-term correction after a period of strong gains. The stock underperformed its sector by 2.99% on the day, touching an intraday low of ₹275.05. This contrasts with the broader Sensex, which has shown modest positive returns over the past week and month. Specifically, while the Sensex gained 0.79% over the last week, Hemant Surgical's shares fell by 5.16% during the same period, indicating a divergence from general market trends.

The stock's current price sits above its 100-day and 200-day moving averages, signalling a longer-term bullish trend. However, it remains below its 5-day, 20-day, and 50-day moving averages, suggesting recent downward momentum. This techn...

Read full news article

Is Hemant Surgical overvalued or undervalued?

2025-11-19 08:10:08

As of 18 November 2025, the valuation grade for Hemant Surgical has moved from very expensive to expensive. The company is currently considered overvalued. Key ratios include a PE ratio of 45.47, an EV to EBITDA of 38.49, and a Price to Book Value of 3.28. In comparison to peers, Max Healthcare has a significantly higher PE ratio of 77.03, while Apollo Hospitals is at 63.51, indicating that Hemant Surgical's valuation remains elevated relative to its competitors. Despite a strong year-to-date return of 124.64% compared to the Sensex's 8.36%, the high valuation ratios suggest that the stock is not justified at its current price of 283.50. The company's ROCE of 8.31% and ROE of 7.22% further indicate that while it has performed well, the market may be pricing in growth that is not fully supported by its financial metrics....

Read full news article

View All News